Dugel Pravin
SEC CIK 1700917 · EDGAR
BoughtSold
Most active insiders at OCUL, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Dugel Pravin | See Remarks, Dir | — | $1.94M |
| 2 | LINDSTROM RICHARD L MD | Dir | $461.4K | — |
| 3 | Saroj Namrata | Chief Business Off | — | $277.8K |
| 4 | Heier Jeffrey S. | CSO | — | $243.3K |
| 5 | Kaiser Peter | Chief Development Off | — | $222.9K |
| 6 | Waheed Nadia | Chief Medical Off | — | $220.9K |
| 7 | Notman Donald | See Remarks | — | $216.1K |
| 8 | Nayak Sanjay | Chief Strategy Off | — | $166.4K |
| 9 | Anderman Todd | CLO | — | $137.4K |
| 10 | Robinson David Wayne | Gbl CCO | — | — |
Transactions 25
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| T | 2026-08-26 17:56 | 2026-08-24 | OCUL | OCULAR THERAPEUTIX, INC | Dugel Pravin | See Remarks, Dir | S - Sale | $10.77 | -21.6K | 2.53M | -0.8% | -$233.2K |
| MTI | 2026-08-26 17:56 | 2026-08-25 | OCUL | OCULAR THERAPEUTIX, INC | Dugel Pravin | See Remarks, Dir | G - Gift | $0.00 | 0 | 744.9K | New | $0 |
| 2026-06-18 16:01 | 2026-06-16 | OCUL | OCULAR THERAPEUTIX, INC | Dugel Pravin | See Remarks, Dir | G - Gift | $0.00 | -50.1K | 2.55M | -2% | $0 | |
| I | 2026-06-18 16:01 | 2026-06-16 | OCUL | OCULAR THERAPEUTIX, INC | Dugel Pravin | See Remarks, Dir | G - Gift | $0.00 | +50.1K | 50.1K | New | $0 |
| T | 2026-05-28 16:08 | 2026-05-26 | OCUL | OCULAR THERAPEUTIX, INC | Dugel Pravin | See Remarks, Dir | S - Sale | $8.20 | -21.2K | 2.60M | -0.8% | -$173.5K |
| MTI | 2026-05-28 16:08 | 2026-05-28 | OCUL | OCULAR THERAPEUTIX, INC | Dugel Pravin | See Remarks, Dir | G - Gift | $0.00 | 0 | 694.8K | New | $0 |
| 2026-04-13 17:15 | 2026-04-09 | OCUL | OCULAR THERAPEUTIX, INC | Dugel Pravin | See Remarks, Dir | G - Gift | $0.00 | -394.7K | 2.62M | -13% | $0 | |
| I | 2026-04-13 17:15 | 2026-04-09 | OCUL | OCULAR THERAPEUTIX, INC | Dugel Pravin | See Remarks, Dir | G - Gift | $0.00 | +394.7K | 394.7K | New | $0 |
| 2026-02-25 | 2026-02-23 | OCUL | OCULAR THERAPEUTIX, INC | Dugel Pravin | See Remarks, Dir | S - Sale | $8.28 | -20.1K | 3.01M | -0.7% | -$166.1K | |
| 2026-02-17 | 2026-02-12 | OCUL | OCULAR THERAPEUTIX, INC | Dugel Pravin | See Remarks, Dir | S - Sale | $9.04 | -124.9K | 3.03M | -4% | -$1.13M | |
| MI | 2025-11-26 | 2025-11-26 | OCUL | OCULAR THERAPEUTIX, INC | Dugel Pravin | See Remarks, Dir | G - Gift | $0.00 | 0 | 0 | New | $0 |
| 2025-11-26 | 2025-11-24 | OCUL | OCULAR THERAPEUTIX, INC | Dugel Pravin | See Remarks, Dir | S - Sale | $12.04 | -19.5K | 3.16M | -0.6% | -$235.1K | |
| 2025-09-11 | 2025-09-09 | OCUL | OCULAR THERAPEUTIX, INC | Dugel Pravin | See Remarks, Dir | G - Gift | $0.00 | -49.8K | 3.18M | -2% | $0 | |
| I | 2025-09-11 | 2025-09-09 | OCUL | OCULAR THERAPEUTIX, INC | Dugel Pravin | See Remarks, Dir | G - Gift | $0.00 | +49.8K | 49.8K | New | $0 |
| 2025-08-27 | 2025-08-25 | OCUL | OCULAR THERAPEUTIX, INC | Dugel Pravin | See Remarks, Dir | S - Sale | $12.04 | -21.5K | 3.23M | -0.7% | -$258.8K | |
| M | 2025-08-13 | 2025-04-28+ | OCUL | OCULAR THERAPEUTIX, INC | Dugel Pravin | See Remarks, Dir | G - Gift | $0.00 | -250.4K | 3.30M | -7% | $0 |
| I | 2025-08-13 | 2025-08-11 | OCUL | OCULAR THERAPEUTIX, INC | Dugel Pravin | See Remarks, Dir | G - Gift | $0.00 | +250.4K | 250.4K | New | $0 |
| 2025-05-27 | 2025-05-23 | OCUL | OCULAR THERAPEUTIX, INC | Dugel Pravin | See Remarks, Dir | S - Sale | $7.18 | -21.2K | 3.50M | -0.6% | -$152.4K | |
| 2025-02-26 | 2025-02-24 | OCUL | OCULAR THERAPEUTIX, INC | Dugel Pravin | See Remarks, Dir | S - Sale | $6.87 | -21.5K | 3.52M | -0.6% | -$147.5K | |
| M | 2025-02-13 | 2025-02-11 | OCUL | OCULAR THERAPEUTIX, INC | Dugel Pravin | See Remarks, Dir | A - Grant | $0.00 | +2.75M | 2.04M | New | $0 |
| 2024-11-27 | 2024-11-25 | OCUL | OCULAR THERAPEUTIX, INC | Dugel Pravin | See Remarks, Dir | S - Sale | $9.01 | -20.7K | 791.8K | -3% | -$186.3K | |
| 2024-08-27 | 2024-08-23 | OCUL | OCULAR THERAPEUTIX, INC | Dugel Pravin | See Remarks, Dir | S - Sale | $9.02 | -20.9K | 812.5K | -3% | -$188.3K | |
| 2024-05-28 | 2024-05-23 | OCUL | OCULAR THERAPEUTIX, INC | Dugel Pravin | See Remarks, Dir | S - Sale | $5.79 | -21.6K | 833.4K | -3% | -$125.2K | |
| D | 2024-02-26 | 2024-02-22 | OCUL | OCULAR THERAPEUTIX, INC | Dugel Pravin | Executive COB, Dir | A - Grant | $0.00 | +855.0K | 855.0K | New | $0 |
| 2021-07-02 | 2021-06-30 | WHWK | Whitehawk Therapeutics, Inc. | Dugel Pravin | Dir | A - Grant | $1.52 | +6,331 | 12.6K | +102% | +$9,623 |
Purchase Sale Sale after option exercise All abbreviations